期刊文献+

血管紧张素II1型受体基因多态性与原发性高血压的关系 被引量:4

Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension.
原文传递
导出
摘要 目的探讨血管紧张素Ⅱ1型受体(AT1R)基因多态性与原发性高血压(EH)之间的关系。方法应用聚合酶链反应-限制性片段长度多态性(PCR—RFLP)对200例汉族EH患者(EH组)和192例正常血压者(对照组)的ATlR基因1166A/C及-810A/T多态性进行检测,测定空腹血糖、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL—C)及高密度脂蛋白胆固醇(HDL—C)等生物化学指标,分析各基因型和等位基因频率与EH的关系。结果1166A/C等位基因和基因型频率在EH组和对照组的分布无统计学差异(P均〉0.05),-810A/T各基因型在EH组和对照组间差异有统计学意义(χ^2=10.862,P=0.004),-810T等位基因频率在EH组显著增高[22.5%(102/400)与11.5%(44/384),χ^2=12.745,P=0.000],用Logistic回归模型校正了传统危险因素的影响后,-810AT和TT基因型的携带者患高血压的危险性显著增加(P=0.003,OR值为2.57,95%CI:1.37~4.84)。结论AT1R-810A/T多态性与EH发病相关,-810T等位基因可能是EH发病的风险因子。 Objective To investigate whether angiotensin II type 1 receptor(AT1R)gene polymorphism is associated with essential hypertension(EH). Methods A total of 200 hypertension patients and 192 normotensive controls were enrolled. The AT1R gene 1166A/C and -810A/T polymorphism were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-PFLP), and the association between the SNPs and the EH were analyzed statistically. Some biochemical index such as serum glucose ( GLU ) and total cholesterol ( TC ), triglyceride (TG), high density lipoprotein (HDL-C) and low density lipoprotein (LDL-C) were also measured. Results There was no significant difference between two groups of 1166A/C polymorphisms of AT1R gene (P 〉 0.05 ). However, for the -810A/T polymorphism of AT1 R gene, -810 AT and TT genotypes frequencies were significantly higher in EH patients than control (P = 0. 004 ). The -810T allele frequencies were higher in case than in control (22.5% vs. 11.5% ;P = 0. 000). We also found an association between EH and -810AT and TT genotypes by logistic regression analysis ( P = 0. 003 ), adjusted for other risk factors. The odds ratio was 2.57 (95% CI:1. 37 -4. 84). Conclusions AT1R -810A/T polymorphism is associated with EH and -810T allele may be a risk factor of hypertension
出处 《中国综合临床》 2010年第10期1047-1049,共3页 Clinical Medicine of China
关键词 血管紧张素Ⅱ1型受体 原发性高血压 基因多态性 Angiotensin II type 1 receptor Essential hypertension Gene polymorphism
  • 相关文献

参考文献9

  • 1牛秋丽,刘雅,温绍君.肾素血管紧张素系统基因多态性与血管紧张素转换酶抑制剂降压疗效的相关性[J].中国医药,2010,5(9):779-781. 被引量:1
  • 2牛建清,李宏芬,沈志霞,范淑英,代琪,张蕴霞.AT1R基因、ACE基因和CYP基因多态性与妊娠期高血压疾病的相关性研究[J].中国综合临床,2009,25(2):121-123. 被引量:2
  • 3Tiret L,Bonnardeaux A,Poirier O,et al.Synergistic effects of angiotensin-converting enzyme and angiotensin-Ⅱ type 1 receptor gene polymorphisms on risk of myocardial infarction[J].Lancet,1994,344(8927):910-913.
  • 4Bonnardeaux A,Davies E,Jeunemaitre X,et al.Angiotensin Ⅱ type 1 receptor gene polymorphisms in human essential hypertension[J].Hypertension,1994,24(1):63-69.
  • 5Lapierre AV,Arce ME,Lopez JR,et al.Angiotensin Ⅱ type 1 receptor A1166C gene polymorphism and essential hypertension in San Luis[J].Biocell,2006,30 (3):447-455.
  • 6刘英,单广良,崔超英,侯淑琴,卓玛次仁,芩维浚,才旦,郑华清,萧占森,乌正赉,周文郁,邱长春.AT_1R基因A1166C多态性与汉、藏和彝族原发性高血压的遗传易感性[J].中华医学遗传学杂志,2003,20(3):220-224. 被引量:14
  • 7Sugimoto K,Katsuya T,Ohkubo T,et al.Association between angiotensin Ⅱ type 1 receptor gene polymorphism and essential hypertension:the Ohasama Study[J].Hypertens Res,2004,27 (8):551-556.
  • 8Jin W,Liu Y,Sheng HH,et al.Single nucleotide polymorphisms in promoter of angiotensin Ⅱ type 1 receptor gene associated with essential hypertension and coronary heart disease in Chinese population[J].Acta Pharmacol Sin,2003,24(11):1083-1088.
  • 9Erdmann J,Riedel K,Rohde K,et al.Characterization of polymorphisms in the promoter of the human angiotensin Ⅱ subtype 1 (AT1) receptor gene[J].Ann Hum Genet,1999,63 (Pt 4):369-374.

二级参考文献36

  • 1刘同宝,商惠萍,张奎星,陈良华,朱兴雷,张怡,朱鼎良,黄薇.血管紧张素转换酶2基因多态性与原发性高血压的关系[J].中华医学遗传学杂志,2005,22(5):569-571. 被引量:21
  • 2布艾加尔.哈斯木,中山智祥,程祖亨,胡大一.肾素基因新的单核甘酸多态性与原发性高血压[J].同济大学学报(医学版),2005,26(6):38-41. 被引量:3
  • 3牛建清,沈志霞,张蕴霞,李宏芬,代琪,王健,范淑英.妊娠期高血压疾病与血管紧张素转换酶基因和血管紧张素Ⅱ-1型受体基因多态性的相关性研究[J].中国医药,2006,1(10):601-603. 被引量:7
  • 4Pirpiris M, Sudhir K, Yeung S, et al. Pressor responsiveness in corti- costeroid-induced hypertension in humans [ J ]. Hypertension, 1992, 19(6 Pt 1) :567-574.
  • 5Mulatero P, Schiavone D, Fallo F, et al. CYP11 B2 gene polymorphisms in idiopathic hyperaldosteronism [ J ]. Hypertension, 2000,35 ( 3 ) :694-698.
  • 6Taymans SE, Pack S, Pak E, et al. Human CYP11 B2 ( aldosterone synthase) maps to chromosome 8q24. 3 [ J ]. J Clin Endocrinol Metab, 1998,83 ( 3 ) : 1033-1036.
  • 7Christ M, Douwes K, Eisen C, et al. Repid effects of aldosterone on sodium transport in vascular smooth muscle ceils [ J ]. Hypertension, 1995,25 ( 1 ) : 117-123.
  • 8Wehling M, Bauer MM, Ulsenheimer A, et al. Nongenomic effects of aldosterone on intracellular pH in vascular smooth muscle cells[ J]. Biochem Biophys Res Commun, 1996,223 ( 1 ) : 181-186.
  • 9Martínez Pérez SR,Armando PD,Molina Guerra AC,et al.Relationship between cardiovascular risk factors and high blood pressure by community pharmacists in Spain.Pharm World Sci,2009,31(3):406-412.
  • 10Morales-Suárez-Varela MM,Mansego ML,Martín-Escudero JC,et al.How ineffective hypertension control in subjects treated with angiotensin-converting enzyme inhibitors is related to polymorphisms in the renin-angiotensin-aldosterone system.Eur J Pharm Sci,2010,39(5):380-386.

共引文献14

同被引文献65

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部